Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
As of January 2026, KFF data shows 13 state Medicaid programs cover GLP-1s for obesity treatment under fee-for-service
Although it contains the same active ingredient as Ozempic, Ozempic is intended for people with Type 2 diabetes
Neurons for hunger and thirst transmit a negative-valence teaching signal
The dual GIP/GLP-1 receptor agonist Tirzepatide (Zepbound ) was approved in 2023 and is the most effective GLP-1RA to date for body weight reduction in individuals with obesity or overweight
However, inhibiting gastric emptying mainly plays a role in reducing postprandial hyperglycaemia, and hence might not be the main mechanism of weight loss (176)
US$ 26.04
US$ 29.20
US$ 21.14
US$ 20.96
US$ 29.73
US$ 28.88
US$ 29.84
US$ 26.61
US$ 23.51
